New Developments | Diabetes Healthy Solutions

Top 5 Breakthroughs for Diabetes

Diabetes is one of the most pressing health issues in the world. According to the ADA (American Diabetes Association), close to 1.5 Americans are diagnosed with diabetes annually. Moreover, in 2017 the CDC (Centers for Disease Control and Prevention) reported that about 100 million people in the United States have prediabetes or diabetes.

One reason why diabetes remains one of the leading causes of death is poor nutrition, processed foods, and too much sugar. Although there’s no cure for diabetes, increased exercise and weight loss can help prevent Type 2 Diabetes.

With the advancements in medicine and technology, we are seeing tremendous improvement in preventing and treating diabetes. There are numerous types of research funded by many organizations such as the World Health Organization, related to finding innovative ways to treat and prevent diabetes.

A new way of preventing the immune system from attacking insulin-producing beta cells

One of the most exciting discoveries in healing diabetes as well as the field of medicine in general is a new way of preventing immune cells from attacking and killing beta cells that produce insulin. Immunotherapy treatment has been proven to be effective in decreasing immunosuppression.

Moreover, the treatment process can be customized for different individuals according to their specific medical state. The main reason why people with diabetes need to use medication is that the body’s ability to produce insulin become s impaired. According to Dr. song’s discovery, suppressing autoimmunity increases the chances of successfully treating Type 1 Diabetes.

Identifying what causes Type 1 Diabetes

In Type 1 Diabetes, the body starts attacking insulin-producing beta cells which hamper the production of insulin and other complications. However, the use of various medications and injections enable patients to lead a normal life by stabilizing the level of insulin in the body.

Therefore, identifying exactly what causes the body to treat insulin-producing beta cells is a major leap towards finding treatment for Type 1 Diabetes. In recent years we have seen major advancement in this field where researchers are studying the possibility of avoiding suppression of the immune system by using immunoglobin to protect beta cells and hence increase insulin production.

Treatment of Diabetic Neuropathy

Patients suffering from neuropathy as a result of diabetes can experience nerve damage which can cause pain and other more serious diabetes-related complications such as sepsis. Neuropathy can also affect the spinal cord and brain.

Although diabetic neuropathy is very hard to treat, there is a new method of treating the condition where molecules are introduced to the body to prevent and potentially reverse neuropathy.

New Technologies for Diabetes

It is essential for diabetics to keep track of their blood glucose levels and blood pressure in order to effectively manage the condition by reacting faster.

Scientists have developed a new device that monitors glucose levels and automatically alerts the patient whenever their glucose levels fall below or rise above the target range. Moreover, we have seen great advancements in blood glucose monitors that have become more accurate, faster, smaller, lighter, and easier to carry around.

New Treatment for Type 2 Diabetes

In addition to the discoveries related to understanding what causes diabetes and finding ways to prevent the condition, there are new types of medication that will help diabetics by preventing side effects and other potential complications caused by diabetes.

Semaglutide, Liraglutide, and Glucagon are 3 new types of tablets that have been proven to be highly effective in the treatment of Type 2 Diabetes.

Semaglutide is a glucagon-based oral medication that should be used 30minutes before any beverage or meal. However, it is not recommended for use as an introductory treatment. In the first month, patients should take 3 mg and increase the dosage of Semaglutide to 7 mg after that.

Glucagon is a nasal powder that has been shown to be an excellent alternative to the injections most diabetes patients have been using. The good news is that it is available for all diabetics aged 4 years and above. However, it is essential to be aware of potential side effects of Semaglutide such as vomiting, headaches, and eye redness.

Liraglutide is recommended for type 2 Diabetes and is best for patients older than 10.

The Bottom line

One of the most important breakthroughs related to diabetes is related to numerous studies that have shown that the main cause of diabetes is poor nutrition and other lifestyle habits, especially among younger generations. Studies show that Type 2 Diabetes is mainly caused by processed foods, fast foods, too much sugar, and a sedentary lifestyle.

Therefore, the most effective way of preventing diabetes is by teaching the younger generation to increase physical activity and most importantly, adopt a healthier diet.

Recent Advances in Diabetes Research

Diabetic Research News!

Scientists have been working on new techniques that have made this an exciting time in diabetes research. Previously, we only had a few promising approaches to finding a cure for diabetes. Now we have numerous possibilities related to prevention and even a cure for both type 1 and type 2 diabetes.

1. Insulin Producing Stem Cell Implants

In July 2017, ViaCyte, a California-based company began clinical trials which involve implanting type 1 diabetes (T1D) patients with the company’s PEC-Direct device. These credit card-sized implants carry cells that are derived from stem cells which are designed to mature into specialized pancreas cells. The implants are placed just below the patient’s skin and are designed to release insulin automatically whenever necessary. The hope is that when these cells mature, they’ll take the place of daily insulin injections by producing insulin when needed.

2. Existing Drug may Prevent onset of Type 1 Diabetes

Scientists from Florida and Colorado have found that a common blood pressure medication could prevent and even treat type 1 diabetes. While the cause of type 1 diabetes remains a mystery, researchers have found that around 60% of people who are at risk of developing T1D possess a molecule known as DQ8 which previous studies have linked to the onset of T1D. Therefore, researchers believe that blocking specifically the DQ8 molecule could help prevent the onset of type 1 diabetes.

Recent studies show that an existing drug known as Methyldopa which is often prescribed to treat hypertension and high blood pressure could also inhibit the DQ8 molecule without interfering with the immune functioning of other cells. The researchers have confirmed their findings in a clinical trial of 20 type 1 diabetes patients. According to the researchers, these findings could have major implications on both the prevention and treatment of autoimmune diseases including diabetes.

3. A New type of Insulin-Producing Beta Cell has been Discovered!

Scientists have found a brand new type of insulin-producing beta cell hiding within the pancreas. This discovery provides insight into how T1D works and also offers new hope into even treating the disease. T1D occurs when the immune system attacks and kills off insulin-producing beta cells. Since insulin helps regulate our blood sugar, T1D patients are left reliant on regular insulin injections.

While type 1 diabetes can be managed effectively, in order to properly treat the condition, scientists need to find a way to regenerate beta cells and prevent the immune system from attacking them in future. Although we are getting better at understanding the mechanisms behind type 1 diabetes and its management, effective treatment for the disease has eluded researches so far. However, the fact that ‘virgin beta cells’ exist opens an entirely new avenue of research on diabetes and potential treatments.

4. A Radical low-calorie diet may lead to diabetes remission.

A new study conducted at GP surgeries in Tyne, UK and Scotland has found that a radical low-calorie diet can help reverse T2D (type 2 diabetes). Following a low-calorie diet that involves consuming 850 calories per day for 3 to 5 months helps decrease fats in the pancreas and the liver hence improving functioning of the pancreatic beta cells, which produce and release insulin. In the study, 46% of the 149 type 2 diabetes patients who followed the weight loss plan achieved remission. However, more research is still needed to help established why some people followed the diet program and lost weight but did not achieve remission.

Try the 5:2 Diet for Diabetes!

5. Transplant of insulin-producing islet cells

A 43-year old woman with difficult-to-control T1D had insulin-producing cells transplanted into the fatty membrane in her stomach cavity. According to the University of Miami researchers, the islet cells started producing insulin at a very fast rate, and after just one year she is doing quite well and no longer needs insulin injections. The researchers are currently exploring ways to optimize insulin-producing islet cell therapy in order to use it on a larger population. This study offers a new transplant approach and is expected to aid research toward developing a new mini-organ known as the BioHub which would mimic the pancreas and act as a temporary home for the transplanted cells. This would help avoid the potential complications associated with using the liver for islet cell transplants.

Scientists believe that these findings will inform future research and help to make life-changing treatments and technologies a reality.

FDA Approved – Abbot’s FreeStyle Pro Bloodless Glucose Meter – Read about it HERE

What are Siren Diabetic Socks?

Siren Diabetes Socks To Help You Manage Your Diabetes

Consumer Electronics Show (CES) 2018 just took place and Siren Diabetic Socks scooped an award for being one of the best innovations.

In a bid to help people through the power of prevention, siren smart diabetic socks help detect problems before they become big ones. These socks help prevent foot ulceration in an effort to prevent and reduce amputations in diabetics through early recognition of ulcerative and pre-ulcerative areas. Thanks to these socks, you can easily keep tabs on any kind of injury and inflammation in real time, all from your feet.

Diabetic Foot swelling is common in both type I and type II diabetes and this can serve as a prelude to serious problems. Therefore, early detection is vital and this is where these cozy socks come into play. Siren Care’s socks use temperature sensors that are woven into the fabric to detect temperature changes. Co-founders veronica Tran and Ran Ma believe they’ve created a novel solution to a serious problem.

How Do Siren Diabetic Socks Work?

Temperature sensors embedded in the socks monitor temperature changes from 6 spots on the feet and transmit them via BLE (Bluetooth Low Energy) to a smartphone. The temperature at each of these specific spots is compared between your feet and if there’s a significant difference, you’ll receive an alert on your smartphone. This helps to reduce false alarms.

Data collected by the socks is stored on your phone and in the cloud in order to ensure that you can monitor your health from any source and from anywhere. Anytime the wearables detect a high-temperature difference, they send data to its companion smart app which will alert you to the potential issue and prompt you to check your feet. This could be as simple as a shoelace that is tucked to your shoe and you can’t feel it and you can easily get injuries from that.

How Long do These Socks Last?

Each wearable lasts 6 months and once you take them off they go to sleep mode to avoid wasting energy. Moreover, they can be thrown to the wash without destroying the sensors and their smart capabilities. According to Ma, the SirenSmart Textile technology can incorporate a wide range of electronics and sensors, including pressure sensors, moisture sensors, light sensors, RFIDs, BLE, MCU, LED’s, etc. seamlessly into fabric.

How Should I Use and Care for the Socks?

Siren Diabetic Socks are sold in a pack of seven pairs to ensure that you have a clean pair of socks each day. Moreover, the socks are waterproof and thus dryer safe and machine washable. You can either connect the sensor data to your smartphone or buy a Siren Plug that you can plug into a wall outlet.

The Siren Plug sends data wirelessly to your wearables to a team of professionals who will notify you of any injuries or potential injuries by texting or calling you. The batteries should last the six months you use the socks without need for replacement. You need to purchase another pack of socks after 6 months.

These socks are designed to comfortably fit your feet and guarantee the highest comfort. They are produced using Neurofabric technology and they feature a padded footbed that cushions the soles of your feet. They are also non-binding to ensure optimum circulation. These socks can be worn at any time with or without shoes just like a normal sock. They can also be worn when exercising.

Is the sock lumpy?

The anklet disk and embedded sensors do not make the socks lumpy because the temperature sensors are incorporated into the fabric and they are designed to send data to the Siren Plug or thee companion app in your phone. The anklet on the sock holds the BLE chip and battery. The anklet has a thin profile and is designed to cover the smallest surface area possible.

Right now Siren Care is calling for all interested parties to join the company’s wait list in order to be among the first to purchase and try their Siren diabetic socks.

Read more about : swelling feet, Foot Pain, Smartphone Diabetes Management Apps

How Concord Hospital Leveraged CPOE to Improve Diabetes Care Processes

Post updated: 20th June 2023

In the ever-evolving landscape of healthcare, technology continues to play a vital role in improving patient outcomes and streamlining care processes. One area where technology has made significant strides is in the management of chronic conditions, such as diabetes.

Concord Hospital, under the guidance of Dr. Joel Berman, has successfully leveraged Computerized Physician Order Entry (CPOE) to enhance diabetes care processes and optimize patient care. This article explores the implementation of CPOE at Concord Hospital and the positive impact it has had on diabetes management.

Understanding CPOE

Computerized Physician Order Entry (CPOE) is a digital system that allows healthcare professionals to enter medical orders, such as medication prescriptions, laboratory tests, and diagnostic procedures, electronically instead of using traditional paper-based methods. By replacing handwritten orders, CPOE reduces the risk of errors, enhances communication between healthcare providers, and promotes efficient workflow.

Implementing CPOE at Concord Hospital

Recognizing the potential benefits of CPOE, Concord Hospital embarked on an ambitious journey to implement this technology in its diabetes care processes. Dr. Joel Berman, an endocrinologist with a passion for leveraging technology to improve patient care, spearheaded the initiative.

His vision was to streamline the ordering process, reduce medication errors, and enhance communication between healthcare providers involved in diabetes management.

To ensure a successful implementation, Dr. Berman collaborated with the hospital’s IT department, nursing staff, and other stakeholders to develop a comprehensive plan. The plan included staff training, workflow analysis, customization of the CPOE system to meet the specific needs of diabetes care, and continuous monitoring and evaluation.

Benefits of CPOE in Diabetes Care:

Improved Medication Safety: CPOE significantly reduces the risk of medication errors by eliminating illegible handwriting and providing decision-support tools. The system alerts healthcare providers to potential drug interactions, allergies, and contraindications, ensuring patients receive the right medications in the appropriate doses.

Enhanced Care Coordination: CPOE enables seamless communication and coordination among healthcare providers involved in diabetes management. Physicians, nurses, dietitians, and pharmacists can access and update patient records in real time, facilitating collaborative decision-making and ensuring consistent care across disciplines.

Efficient Workflow: The implementation of CPOE has streamlined the ordering process, eliminating the need for paper-based order transcription and reducing the time required for order processing. Healthcare providers can access patient information and submit orders electronically, resulting in faster turnaround times and improved efficiency.

Real-time Clinical Decision Support: CPOE systems offer real-time clinical decision support, providing healthcare providers with evidence-based guidelines, protocols, and alerts. This functionality assists clinicians in making informed decisions, adhering to best practices, and optimizing diabetes care management.

Data-driven Insights: By leveraging CPOE, Concord Hospital has access to a wealth of data that can be used for quality improvement initiatives and clinical research. Analysis of CPOE data allows for identifying trends, monitoring performance indicators, and implementing targeted interventions to enhance patient outcomes.

Positive Outcomes at Concord Hospital

The implementation of CPOE at Concord Hospital has yielded several positive outcomes, resulting in improved diabetes care processes and patient outcomes. The system’s decision support tools have led to a significant reduction in medication errors, ensuring patients receive safe and appropriate treatments.

Care coordination has been enhanced, enabling seamless communication among healthcare providers, resulting in a more holistic and patient-centered approach to care.

Furthermore, the efficient workflow facilitated by CPOE has decreased order processing time, allowing for timely interventions and faster delivery of care. Real-time clinical decision support has empowered healthcare providers with evidence-based guidelines, enhancing the quality of diabetes care provided at the hospital.

Lastly, the data collected through CPOE has opened new avenues for research and quality improvement initiatives, contributing to continuous advancements in diabetes management.

In conclusion

Concord Hospital’s successful implementation of CPOE in diabetes care processes, led by Dr. Joel Berman, exemplifies the transformative power of technology in healthcare. By leveraging CPOE, the hospital has achieved significant improvements in medication safety, care coordination, workflow efficiency, clinical decision-making, and data-driven insights.

The experience of Concord Hospital serves as a shining example for healthcare organizations seeking to enhance diabetes care and optimize patient outcomes through the effective utilization of technology. As the healthcare landscape continues to evolve, embracing technological innovations like CPOE will undoubtedly play a pivotal role in shaping the future of patient care.

Read the total edition of this CPOE case review, or learn more about the Horizon Specialist Orders Computerized Medical Doctor Order Entry (CPOE) resolution by going to McKesson.

A new way of preventing the immune system from attacking insulin-producing beta cells

Identifying what causes Type 1 Diabetes

Treatment of Diabetic Neuropathy

New Technologies for Diabetes

New Treatment for Type 2 Diabetes